Exp Clin Endocrinol Diabetes 1983; 81(1): 49-58
DOI: 10.1055/s-0029-1210206
Original

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Insulin Receptor Binding and Insulin-Mediated Glucose Uptake in Type-II-Diabetics

B. Schulz, L. Doberne, M. Greenfield, G. M. Reaven
  • Clinical Research Center (Director: G. M. Reaven, M.D.), Stanford University School of Medicine, Stanford, California/USA and Central Institute of Diabetes “Gerhardt Katsch” (Director: Prof. Dr. sc. med. H. Bibergeil), Karlsburg/GDR
Weitere Informationen

Publikationsverlauf

1982

Publikationsdatum:
17. Juli 2009 (online)

Summary

A 5-hour insulin clamp was performed, in 7 normal subjects (N) and 6 type-II-diabetics. After a 10-min-priming insulin infusion, a constant infusion of 1.813 μg/m2 s.a./min was given to all subjects. Glycemia was kept at fasting levels by a variable glucose infusion. Under these conditions the amount of metabolized glucose (M) has been calculated and served as a measure of insulin-stimulated glucose disposal. M differed markedly between N (35.6 ± 3.11 μmol glucose/kg b.w./min and diabetics (17.8 ± 1.17 µmol glucose/kg b.w./min; p < 0.01) indicating a diminished insulin sensitivity in the latter group. However, M increased slightly but significantly until the end of the study in both groups. Under fasting conditions the mean percent 125I-insulin specifically bound to 3.5 ×109 erythrocytes/ml at tracer concentrations was 12 ± 1.2% and 8.9 ± 0.9% in N and diabetics, respectively. During insulin infusion specific insulin binding decreased significantly in both groups by 34% and 41%. Thus, the downregulation of insulin binding was similar in both groups and was due to changes in receptor affinity.

Assuming that insulin binding to red blood cells mimic that to target cells we conclude that the cause of reduced glucose utilization in type-II-diabetes lies mainly in changes of postreceptor events rather than in receptor binding.

    >